Trontinemab

Trontinemab is a monoclonal antibody developed by Roche/Genentech for the treatment of Alzheimer's disease. It is based on gantenerumab, an anti-amyloid monoclonal antibody, and using a Brainshuttle domain for... Wikipedia

• Legal status:  Investigational
• CAS Number:  2568868-35-7
• ATC code:  ATC code
• UNII:  N0GBZ1GWC2
• Synonyms:  RG6102
• Data source:  DuckDuckGo